Sutro Biopharma, Inc.
STRO
$0.7991
-$0.0122-1.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.43% | -18.38% | -8.86% | 36.00% | -16.61% |
| Total Receivables | 57.40% | 29.47% | -4.24% | -77.80% | -13.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.76% | 63.74% | 3.20% | 4.66% | 2.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.28% | -15.39% | -8.50% | 25.07% | -15.88% |
|
|
|||||
| Total Current Assets | -16.28% | -15.39% | -8.50% | 25.07% | -15.88% |
| Net Property, Plant & Equipment | -7.78% | -5.67% | -4.33% | -5.87% | -5.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -88.26% | 0.01% | 37.93% | -11.75% | 48.59% |
| Total Assets | -16.99% | -14.30% | -7.61% | 21.23% | -14.30% |
|
|
|||||
| Total Accounts Payable | -21.91% | 68.52% | 2.14% | -18.97% | -20.43% |
| Total Accrued Expenses | -15.39% | -4.08% | 6.15% | 50.13% | -23.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.81% | 3.85% | 3.89% | 3.90% | -36.33% |
| Total Finance Division Other Current Liabilities | 12.65% | -2.93% | -1.96% | 98.48% | -1.65% |
| Total Other Current Liabilities | 12.65% | -2.93% | -1.96% | 98.48% | -1.65% |
| Total Current Liabilities | 0.87% | 0.46% | 1.00% | 63.48% | -15.19% |
|
|
|||||
| Total Current Liabilities | 0.87% | 0.46% | 1.00% | 63.48% | -15.19% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.03% | -11.25% | -9.86% | -8.43% | -7.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.83% | 1.76% | 2.33% | -8.40% | 0.14% |
| Total Liabilities | 1.35% | 0.59% | 1.11% | 10.31% | -4.89% |
|
|
|||||
| Common Stock & APIC | 0.67% | 0.71% | 0.92% | 14.28% | 0.95% |
| Retained Earnings | -9.65% | -10.14% | -7.33% | -7.77% | -10.41% |
| Treasury Stock & Other | -123.08% | -63.21% | 165.03% | -44.25% | -638.10% |
| Total Common Equity | -157.87% | -59.90% | -26.91% | 55.24% | -34.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -157.87% | -59.90% | -26.91% | 55.24% | -34.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -157.87% | -59.90% | -26.91% | 55.24% | -34.50% |
|
|
|||||